Mild Cognitive Impairment

Mild Cognitive Impairment (MCI) marks a critical stage preceding Alzheimer's Disease and other types of dementia. It involves subtle changes in cognitive functions like memory and reasoning that exceed normal age-related decline. While individuals with MCI may struggle with remembering recent events or making decisions, these challenges typically do not significantly disrupt daily life.

Understanding MCI's significance lies in its potential progression to dementia, although this progression isn't inevitable. Some individuals with MCI remain stable or may even show improvement over time. Early detection and intervention are vital, as lifestyle adjustments, cognitive training, and certain medications could potentially slow down or manage further cognitive decline.

Ongoing research aims to deepen our understanding of MCI's origins, risk factors, and effective interventions, with the goal of improving outcomes and enhancing the quality of life for individuals at risk of developing dementia.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp